Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Leuprolide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR known ✓ | P30968 | 2/20 | 0.84 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.87 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.78 |
| ▸ | APLNR | P35414 | 5/20 | 0.65 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leuprolide SCHEMBL177978 | 1.00 | ABCC2 (0.87) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL847084 | 1.00 | ABCC2 (0.87) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL3174 | 1.00 | ABCC2 (0.87) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Deslorelin SCHEMBL1649660 | 0.99 | GNRHR (0.86) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL10061885 | 0.99 | GNRHR (0.86) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL21540132 | 0.99 | GNRHR (0.86) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL4585 | 0.99 | GNRHR (0.86) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL7751433 | 0.99 | GNRHR (0.86) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL4414320 | 0.98 | ABCC2 (0.84) | ABCC2GNRHRPTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL3915060 | 0.98 | GNRHR (0.86) | ABCC2GNRHRPTGS1APLNRCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013116061-A1 | INSERTION AND REMOVAL METHODS AND APPARATUS FOR THERAPEUTIC DEVICES | FORSIGHT VISION4, INC. (US) | 2013-08-08 | — | — | WO | disclosed |
| EP-2600812-A2 | IMPLANTABLE THERAPEUTIC DEVICE | Forsight Vision4, Inc. (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012019176-A2 | IMPLANTABLE THERAPEUTIC DEVICE | FORSIGHT VISION4 INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| US-5981489-A | NONAQUEOUS PEPTIDE COMPOUND WHICH CONSISTS ESSENTIALLY OF ABOUT 30% TO ABOUT 50% (W/W) OF THE LHRH-RELATED COMPOUND LEUPROLILDE ACETATE IN POLYOXYETHYLENE GLCOL OR MIXTURE | ALZA CORPORATION (US) | 1999-11-09 | — | — | US | disclosed |